Farmers are constantly looking for better ways to care for our crops, protect our animals and keep our farms sustainable for ...
18hon MSN
New 'SMArT' platform makes gene editing in hematopoietic stem cells more efficient and safer
A team of researchers led by Luigi Naldini at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) has developed a ...
An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...
Researchers developed PRINCE, a small-molecule-controlled CRISPR system enabling precise, long-term regulation of gene editing.
Volatile macroeconomic events are magnified in life science and healthcare applications, which are capital intensive, long-term investments with associated regulatory, safety, and commercial risks.
Gene editing is now reaching the mainstream, ushering in a new era of genetic manipulation. Traditionally, inserting or deleting entire genes, regulating their expression, and altering specific ...
The Chosun Ilbo on MSN
Big Pharma eyes $80 billion gene therapy market
U.S. pharmaceutical company Eli Lilly announced on the 25th (local time) interim results from Phase 1 clinical trials of ...
You’re reading Book Currents, a weekly column in which notable figures share what they’re reading. Sign up for the Goings On newsletter to receive their selections, and other cultural recommendations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results